Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Blueprint Genetics | RCV001074897 | SCV001240501 | pathogenic | Retinal dystrophy | 2019-08-14 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV002513921 | SCV003444643 | pathogenic | Primary ciliary dyskinesia | 2024-12-03 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Asn34Metfs*34) in the RPGR gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in RPGR are known to be pathogenic (PMID: 16055928, 16969763). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with retinitis pigmentosa (PMID: 11180598, 31953110). This variant is also known as 160delA. ClinVar contains an entry for this variant (Variation ID: 98815). For these reasons, this variant has been classified as Pathogenic. |
Retina International | RCV000085138 | SCV000117275 | not provided | not provided | no assertion provided | not provided |